JPRN-UMIN000013194已完成3 期
The efficacy and safety of third line H. pylori eradication therapy with sitafloxacin, amoxicillin and PPI - The efficacy of third line H. pylori eradication therapy with sitafloxacin, amoxicillin and PPI
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with allergy for quinolones 2. Patients with allergy for PPIs 3. Patients with severe liver injury and/or severe renal damage 4. Pregnancy or possible pregnancy 5. Patients who were recognized as inappropriate for entry
研究者
相似试验
已完成
3 期
The efficacy and safety of third line H. pylori eradication therapy with sitafloxacin, metronidazole and PPIH. pylori-positve patients after the 2nd line eradication failure or penicillin-allergic patientsJPRN-UMIN000013195Keio University School of Medicine100
已完成
不适用
Analysis of third-line H. pylori eradication therapy with sitafloxaciPatients with H. pylori eradication failure after first- and second-line therapyJPRN-UMIN000001902Department of Gastroenterology, University of Tokyo50
已完成
不适用
The study of H.pylori third line eradication therapy using VonoprazaHelicobacter pylori infectionJPRN-UMIN000024290ational Hospital Organization National Kochi Hospital gstroenterology10
已完成
3 期
Effect of the three-drug regimen of H. Pylori eradication with and without probiotics on the eradication treatmentH. Pylori infection.Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhereB96.81IRCT20120215009014N344Hamedan University of Medical Sciences150
已完成
2 期
Effect of three-drug regimen against H. pylori infection versus four-drug regiment in patients with dyspepsia or peptic ulcer diseaseDyspepsia.DyspepsiaIRCT201605189014N100Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences150